Cargando…
Minicircle-oriP-IFNγ: A Novel Targeted Gene Therapeutic System for EBV Positive Human Nasopharyngeal Carcinoma
BACKGROUND: Nonviral vectors are attractively used for gene therapy owing to their distinctive advantages. Our previous study has demonstrated that transfer of human IFNγ gene into nasopharyngeal carcinoma (NPC) by using a novel nonviral vector, minicircle (mc), under the control of cytomegalovirus...
Autores principales: | Zuo, Yufang, Wu, Jiangxue, Xu, Zumin, Yang, Shiping, Yan, Haijiao, Tan, Li, Meng, Xiangqi, Ying, Xiaofang, Liu, Ranyi, Kang, Tiebang, Huang, Wenlin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088667/ https://www.ncbi.nlm.nih.gov/pubmed/21573215 http://dx.doi.org/10.1371/journal.pone.0019407 |
Ejemplares similares
-
Regulated expression of a transgene introduced on an oriP/EBNA-1 PAC shuttle vector into human cells
por: Askautrud, Hanne A, et al.
Publicado: (2009) -
Cryptochrome 1 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer
por: Yu, Hongyan, et al.
Publicado: (2013) -
Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy
por: Suzuki, Hitoshi, et al.
Publicado: (2009) -
Retrofitting BACs with G418 resistance, luciferase, and oriP and EBNA-1 – new vectors for in vitro and in vivo delivery
por: Magin-Lachmann, Christine, et al.
Publicado: (2003) -
Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system
por: Drozd, Anna M., et al.
Publicado: (2015)